Skip to main navigation Skip to search Skip to main content

Prostate cancer early detection, version 2.2015: Clinical practice guidelines in oncology

  • Peter R. Carroll
  • , J. Kellogg Parsons
  • , Gerald Andriole
  • , Robert R. Bahnson
  • , Daniel A. Barocas
  • , Erik P. Castle
  • , William J. Catalona
  • , Douglas M. Dahl
  • , John W. Davis
  • , Jonathan I. Epstein
  • , Ruth B. Etzioni
  • , Thomas Farrington
  • , George P. Hemstreet
  • , Mark H. Kawachi
  • , Paul H. Lange
  • , Kevin R. Loughlin
  • , William Lowrance
  • , Paul Maroni
  • , James Mohler
  • , Todd M. Morgan
  • Robert B. Nadler, Michael Poch, Chuck Scales, Terrence M. Shaneyfelt, Marc C. Smaldone, Geoffrey Sonn, Preston Sprenke, Andrew J. Vickers, Robert Wake, Dorothy A. Shead, Deborah Freedman-Cass
  • University of California at San Francisco
  • University of California at San Diego
  • Washington University St. Louis
  • Ohio State University
  • Vanderbilt University
  • Mayo Clinic Rochester, MN
  • Northwestern University
  • Massachusetts General Hospital
  • University of Texas MD Anderson Cancer Center
  • Johns Hopkins University
  • Seattle Cancer Care Alliance
  • Prostate Health Education Network
  • University of Nebraska Medical Center
  • City of Hope National Med Center
  • Dana-Farber/Brigham and Women's Cancer Center
  • University of Utah
  • University of Colorado Anschutz Medical Campus
  • University of Michigan, Ann Arbor
  • Moffitt Cancer Center
  • Duke University
  • University of Alabama at Birmingham
  • Fox Chase Cancer Center
  • Stanford University
  • Yale University
  • Memorial Sloan-Kettering Cancer Center
  • St. Jude Children Research Hospital

Research output: Contribution to journalArticlepeer-review

56 Scopus citations

Abstract

Prostate cancer represents a spectrum of disease that ranges from nonaggressive, slow-growing disease that may not require treatment to aggressive, fast-growing disease that does. The NCCN Guidelines for Prostate Cancer Early Detection provide a set of sequential recommendations detailing a screening and evaluation strategy for maximizing the detection of prostate cancer that is potentially curable and that, if left undetected, represents a risk to the patient. The guidelines were developed for healthy men who have elected to participate in the early detection of prostate cancer, and they focus on minimizing unnecessary procedures and limiting the detection of indolent disease.

Original languageEnglish
Pages (from-to)1534-1561
Number of pages28
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume13
Issue number12
DOIs
StatePublished - Dec 1 2015

Fingerprint

Dive into the research topics of 'Prostate cancer early detection, version 2.2015: Clinical practice guidelines in oncology'. Together they form a unique fingerprint.

Cite this